| Literature DB >> 28250385 |
Olga Loseva1, Emman Shubbar2, Siamak Haghdoost3, Bastiaan Evers4, Thomas Helleday5, Mats Harms-Ringdahl6.
Abstract
The risks of non-cancerous diseases associated with exposure to low doses of radiation are at present not validated by epidemiological data, and pose a great challenge to the scientific community of radiation protection research. Here, we show that premature senescence is induced in human fibroblasts when exposed to chronic low dose rate (LDR) exposure (5 or 15 mGy/h) of gamma rays from a 137Cs source. Using a proteomic approach we determined differentially expressed proteins in cells after chronic LDR radiation compared to control cells. We identified numerous proteins involved in protection against oxidative stress, suggesting that these pathways protect against premature senescence. In order to further study the role of oxidative stress for radiation induced premature senescence, we also used human fibroblasts, isolated from a patient with a congenital deficiency in glutathione synthetase (GS). We found that these GS deficient cells entered premature senescence after a significantly shorter time of chronic LDR exposure as compared to the GS proficient cells. In conclusion, we show that chronic LDR exposure induces premature senescence in human fibroblasts, and propose that a stress induced increase in reactive oxygen species (ROS) is mechanistically involved.Entities:
Keywords: human fibroblasts; ionizing radiation; low dose chronic exposure; premature senescence; proteomics
Year: 2014 PMID: 28250385 PMCID: PMC5302754 DOI: 10.3390/proteomes2030341
Source DB: PubMed Journal: Proteomes ISSN: 2227-7382
Figure 1Panel (A): Growth rate kinetics of VH10 cells in response to chronic dose of 5 (□) and 15 (×) mGy/h γ-rays as well as for non-exposed cells (■). The results are based on 3 independent experiments (n = 3) for each dose rate that were started from passage 12. The slopes of growth rate for each experiment have been calculated and used to test the significance between the growth rates of non-exposed and exposed cells; Panel (B): The senescence-associated β-galactosidase staining of VH10 cells. Fibroblasts at early (20 days of culture), late and senescent passages (days of culture as shown in C) were subjected to in situ SA-βgal staining at pH 6 and examined by bright field microscopy. Cellular senescence is evident by flattened cell morphology, growth arrest and augmented senescence-associated β-galactosidase activity (numbers in brackets represent percent of β-galactosidase active cells); Panel (C): Western blots showing the expression of p53, p21 and p16. VH10 cells were harvested at early-, late-passages and senescent stages. Total protein extract were subjected to SDS-PAGE and Western blotting. The membranes were developed with antibodies for p53, p21, p16 and actin as control. Data are representative of two independent experiments.
Figure 2Panel (A): Representative 2D maps of proteins in control VH10 cells and after 65 days of low dose chronic exposure. 100 µg proteins were loaded and separated in the first dimension by IEF on IPG strips with nonlinear pH 3–10 gradient, then in the second dimension by SDS/PAGE on 10% polyacrylamide gels. Proteins were revealed by silver nitrate staining. The numbered proteins were identified by mass spectrometry and listed in Table 1; Panel (B): 2D gel images showing selected up-regulated proteins after 20, 50, 65 and 76 days (senescence) chronic exposure at 15 mGy/h; Panel (C): The diagram presents comparison of numbers of senescence-associated proteins in the control and two irradiated samples.
Figure 3The heat map showing senescence-associated changes in relative level of differentially expressed proteins in the control and irradiated cells. Integrated intensity of protein spots on 2DE gels was determined by PDQuest 8.0.1 (Bio-Rad) at indicated time points for samples of control cells and cells continuously receiving 5 mGy/h or 15 mGy/h. Panel (A): The relative spot intensity of differentially regulated proteins in treated samples compared to untreated controls is shown. Proteins are grouped according to function; Panel (B): Unsupervised hierarchical clustering on the 15 mGy/h samples reveals groups of proteins that are up-regulated early, intermediate and late after irradiation. Depicted are log10 values of protein levels in treated cells normalized to levels in untreated cells of the same time point.
Identification of proteins differentially expressed after low dose chronic exposure in normal human fibroblast VH10 cells.
| Spot Number | Protein Name | Protein ID | Theoretical pI | Theoretical Mr, kDa | Peptide Matches | Sequence Coverage % | Mascot Score | Protein Function |
|---|---|---|---|---|---|---|---|---|
| 1 | α-Enolase | P06733 | 7.0 | 47.2 | 15 | 36 | 120 | Glycolysis |
| 2 | α-Enolase | P06733 | 7.0 | 47.2 | 20 | 33 | 197 | Glycolysis |
| 3 | Proliferation-associated protein 2G4 | Q9UQ80 | 6.1 | 43.8 | 14 | 27 | 66 | Involved in cell cycle arrest/cell proliferation |
| 4 | 26S protease regulatory subunit 8 | P62195 | 7.1 | 45.6 | 12 | 36 | 85 | Proteasome complex |
| 5 | Mannose-6-phosphate receptor-binding protein 1 | O60664 | 5.8 | 28.1 | 15 | 48 | 141 | Vesicle-mediated transport |
| 6 | Serine-threonine kinase receptor-associated protein | Q9Y3F4 | 5.0 | 38.4 | 9 | 41 | 70 | mRNA processing, regulator of TGFβ pathway, cofactor of p53 |
| 7 | Serine-threonine kinase receptor-associated protein | Q9Y3F4 | 5.0 | 38.4 | 8 | 32 | 65 | mRNA processing, regulator of TGFβ pathway, cofactor of p53 |
| 8 | Alcohol dehydrogenase | P14550 | 6.3 | 36.6 | 13 | 55 | 110 | Glucose metabolic process |
| 9 | LIM and SH3 domain protein 1 | Q14847 | 6.4 | 30.1 | 10 | 31 | 75 | Actin-binding protein |
| 10 | Eukaryotic translation initiation factor 3 | Q13347 | 5.4 | 36.5 | 9 | 30 | 71 | Protein biosynthesis |
| 11 | Eukaryotic translation initiation factor 3 | Q13347 | 5.4 | 36.5 | 10 | 32 | 73 | Protein biosynthesis |
| 12 | F-actin-capping protein α-1 | P52907 | 5.4 | 32.9 | 14 | 67 | 172 | Regulation of cell motility |
| 13 | Tubulin beta | P07437 | 4.8 | 48.7 | 14 | 45 | 132 | Cytoskeleton |
| 14 | Annexin A1 | P04083 | 6.6 | 38.7 | 18 | 52 | 179 | Regulation of apoptosis |
| 15 | Annexin A1 | P04083 | 6.6 | 38.7 | 19 | 62 | 202 | Regulation of apoptosis |
| 16 | PDZ and LIM domain protein 1 | O00151 | 6.6 | 36.5 | 9 | 23 | 78 | Cytoskeleton protein required for actin stress fiber formation |
| 17 | F-actin-capping protein subunit β | P47756 | 5.4 | 31.5 | 9 | 44 | 67 | Actin-binding protein |
| 18 | Chloride intracellular channel protein CLIP1 | O00299 | 5.1 | 27.4 | 16 | 70 | 183 | Chloride ion channel, anti-apoptotic |
| 19 | Annexin A2 | P07355 | 7.6 | 38.6 | 20 | 51 | 210 | Stress response, regulation of apoptosis |
| 20 | Glutathione transferase omega-1 | P78417 | 6.2 | 27.8 | 10 | 29 | 100 | Metabolism of xenobiotics, antioxidant |
| 21 | Heat shock protein β-1 (Hsp27) | P04792 | 6.0 | 22.8 | 8 | 38 | 65 | Involved in stress resistance and actin organization |
| 22 | Phosphoglycerate mutase | P18669 | 6.4 | 26.7 | 18 | 73 | 200 | Glycolysis |
| 23 | Ubiquitin thiolesterase L1, acidic isoforms | P09936 | 5.3 | 24.8 | 14 | 72 | 131 | Processing of ubiquitinated proteins; anti-apoptotic |
| 24 | Ubiquitin thiolesterase L1, basic isoforms | P09936 | 5.3 | 24.8 | 14 | 75 | 171 | Processing of ubiquitinated proteins; anti-apoptotic |
| 25 | Peroxiredoxin 6 | P30041 | 6.0 | 25.0 | 7 | 36 | 57 | Antioxidant |
| 26 | Peroxiredoxin 6 | P30041 | 6.0 | 25.0 | 13 | 64 | 144 | Antioxidant |
| 27 | Peroxiredoxin 6 | P30041 | 6.0 | 25.0 | 14 | 70 | 155 | Antioxidant |
| 28 | Triosephosphate isomerase | P60174 | 6.4 | 26.7 | 15 | 58 | 177 | Carbohydrate metabolism |
| 29 | 26S proteasome subunit 10 | O75832 | 5.4 | 20.4 | 8 | 49 | 58 | Acts as a regulatory subunit of the 26S proteasome |
| 30 | Glutathione S-transferase P | P09211 | 5.4 | 23.6 | 9 | 48 | 94 | Antioxidant, anti-apoptotic |
| 31 | Glutathione S-transferase P | P09211 | 5.4 | 23.6 | 10 | 56 | 146 | Antioxidant, anti-apoptotic |
| 32 | Protein DJ-1 | Q99497 | 6.3 | 19.9 | 8 | 43 | 60 | Redox-sensitive chaperone and a sensor for oxidative stress |
| 33 | Proteasome subunit α type-2 | P25787 | 6.9 | 26.0 | 8 | 44 | 70 | Proteasome complex |
| 34 | Acyl-protein thioesterase 1 | O75608 | 6.3 | 26.7 | 5 | 41 | 56 | De-palmitoylation of signaling proteins |
| 35 | Superoxide dismutase Mn SOD2 | P04179 | 8.3 | 24.7 | 7 | 36 | 69 | Antioxidant, age-dependent response to ROS |
| 36 | Superoxide dismutase Mn SOD2 | P04179 | 8.3 | 24.7 | 8 | 40 | 78 | Antioxidant, age-dependent response to ROS |
| 37 | Peroxiredoxin-2 | P32119 | 5.7 | 21.9 | 9 | 35 | 79 | Antioxidant, anti-apoptotic |
| 38 | Adenine phosphoribosyltransferase | P07741 | 5.8 | 19.6 | 8 | 68 | 91 | Nucleotide metabolism |
| 39 | Nucleoside diphosphate kinase A | P15531 | 5.8 | 17.3 | 8 | 61 | 90 | Synthesis of nucleoside triphosphates other than ATP, tumor suppressor, cofactor of p53 |
| 40 | Transgelin | Q01995 | 8.9 | 22.6 | 13 | 56 | 121 | Actin-binding protein, senescence marker |
The spot numbers refer to Figure 2A. Protein ID number and predicted protein function are found at UniProtKB [25]. The numbers of identified peptides matching predicted peptides and coverage of the entire protein sequence by the identified tryptic peptides are presented. Mascot Scores greater than 56 are considered significant (p ≤ 0.05).
Figure 4Panel (A): Growth rate kinetics of human fibroblast deficient in GS in response to chronic dose of 5 (□) and 15 (×) mGy/h γ-rays as well as for non-exposed cells (■). The results are based on 3 independent experiments (n = 3) for each dose rate; Panel (B): The quantification of SA-βgal staining in GS deficient fibroblast after 3 weeks of chronic exposure to γ-rays are based on 3 independent experiments (n = 3). The exposed cells were subjected to in situ SA-βgal staining at pH 6 and examined by bright field phase microscopy. The SA-βgal positive cells are presented as % of total number of the investigated cells.